COVID-19
Pharmafile.com’s weekly COVID-19 news round-up
December 2, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, Image credit: CDC, Top 5, Vaccine
EMA receives Pfizer and BioNTech’s filing for conditional approval of COVID-19 vaccine in Europe – Published on 01/12/20
UK becomes first nation to approve Pfizer and BioNTech’s COVID-19 vaccine
December 2, 2020Research and Development, Sales and Marketing COVID-19, Pfizer, UK, Vaccine
The UK has become the first country worldwide to authorise Pfizer and BioNTech’s promising COVID-19 vaccine, the UK Government has …
EMA receives Pfizer and BioNTech’s filing for conditional approval of COVID-19 vaccine in Europe
December 1, 2020Manufacturing and Production, Sales and Marketing BioNTech, COVID-19, EMA, Pfizer, Vaccine
Pfizer and BioNTech have officially submitted their application to secure conditional marketing authorisation to the European Medicines Agency (EMA) for …
Analysis confirms Moderna’s COVID-19 vaccine efficacy to be 94.1%
November 30, 2020Research and Development, Sales and Marketing COVID-19, Moderna, Vaccine
US biotech Moderna has followed up on its highly promising efficacy data for its mRNA-based COVID-19 vaccine candidate with the …
UK secures another two million COVID-19 vaccine doses from Moderna
November 30, 2020Sales and Marketing COVID-19, Moderna, UK
The UK Government has expanded upon its previous negotiations with Moderna to secure an additional two million doses of its …
Philippines poised to secure two million AstraZeneca COVID-19 vaccine doses
November 26, 2020Manufacturing and Production AstraZeneca, COVID-19, Vaccine
The Philippines is set to imminently seal a deal with AstraZeneca for two million doses of AstraZeneca’s COVID-19 vaccine, it …
Canada secures 26,000 doses of Lilly therapy to treat COVID-19 in $32.5m deal
November 25, 2020Manufacturing and Production, Research and Development COVID-19, Canada
The Canadian Government has partnered up with Eli Lilly to secure 26,000 doses of the company’s monoclonal antibody therapy bamlanivimab …
The December 2020 issue of Pharmafocus is available to read free online now!
November 24, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, clinical trials, diabetes, outsourcing
The final 2020 monthly edition of Pharmafocus is available to read for free online now! After a long and theatrical …
Russia’s Sputnik COVID-19 vaccine has 91.4% efficacy after 28 days, new interim data show
November 24, 2020Manufacturing and Production, Research and Development COVID-19, Sputnik V, Vaccine
The National Research Center for Epidemiology and Microbiology and the Russian Direct Investment Fund (RDIF) have released a statement saying …
Interim analysis for AstraZeneca’s COVID-19 vaccine finds 70% average efficacy
November 23, 2020Research and Development, Sales and Marketing AstraZeneca, COVID-19, Vaccine
Hot on the heels of Moderna and Pfizer/BioNTech who both have released very promising data for their mRNA COVID-19 vaccine …
Pfizer and BioNTech to request FDA Emergency Use Authorisation for their COVID-19 vaccine today
November 20, 2020Medical Communications, Sales and Marketing BioNTech, COVID-19, Pfizer, Vaccine
Pfizer and BioNTech are reportedly gearing up to submit a formal application for Emergency Use Authorisation to the FDA later …
Pfizer/BioNTech’s COVID-19 vaccine shows up to 95% efficacy in final analysis, including in over-65s
November 18, 2020Research and Development BioNTech, COVID-19, Pfizer, Vaccine
Pfizer and BioNTech have backed up their promising interim Phase 3 data showing 90% efficacy for their COVID-19 vaccine candidate …
Renewed BARDA backing boosts J&J’s COVID-19 vaccine funding by $1bn
November 17, 2020Manufacturing and Production, Research and Development BARDA, COVID-19, J&J, JJ, Janssen, Vaccine
Johnson & Johnson has said that it is injecting around $1 billion of funding into its research efforts to develop …
UK secures 5m doses of Moderna’s vaccine after it shows 94.5% interim efficacy
November 17, 2020Manufacturing and Production, Research and Development, Sales and Marketing COVID-19, Moderna, UK, Vaccine
US firm Moderna has swooped in with Phase 3 interim data for its own messenger RNA (mRNA) vaccine candidate, mRNA-1273, …
BioNTech Chief says COVID-19 vaccine could mean “normal winter” next year
November 16, 2020Research and Development, Sales and Marketing BioNTech, COVID-19, Pfizer, Vaccine
The advent of an effective vaccine could mean a return to normalcy by next winter, argues Professor Uğur Şahin, Professor …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
